BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2010
View Archived Issues
GO-CoA-Tat controls glucose and weight in preclinical study
Read More
Merck & Co. identifies novel glucocorticoid receptor modulators
Read More
Asymmetrical CADA analogue VGD-020 displays improved potency against CD4
Read More
In vitro data support potential benefits of TT-30 in complement-mediated diseases
Read More
New CREB-1 inhibitor XX-650-23 shows promise to treat AML
Read More
Pfizer identifies new GPR119 agonists
Read More
New antagonists of protease-activated PAR1 receptor claimed
Read More
Leo Pharma claims new positive modulators of calcium-sensing CaS receptor
Read More
Vertex Pharma patents new inhibitors of hepatocyte growth factor receptor
Read More
Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy
Read More
Pro-Pharmaceuticals and Mount Sinai School of Medicine to evaluate galectin-targeting agents
Read More
King Pharmaceuticals resubmits Remoxy NDA to FDA
Read More
Degludec improves long-term glycemic control in phase IIIa diabetes trials
Read More
Exiqon offers services for microRNA biomarker screening and diagnostic assay development
Read More
AVI BioPharma advances Duchenne's muscular dystrophy program
Read More
Transition Therapeutics and Elan modify ELND-005 collaboration agreement
Read More
Cephalon discontinues development of Nuvigil for jet lag
Read More
FDA reports on ongoing safety review of somatropin
Read More
European release of Xpert Flu test for influenza A, B and 2009 H1N1 strain
Read More
Vicus begins phase II trial of VT-122 in advanced HCC
Read More
Repros completes preclinical studies of vaginal Proellex formulation
Read More
European sale of Ruconest begins in Denmark and Norway
Read More
EMA to review Allos' MAA for Folotyn in relapsed or refractory PTCL
Read More
Emergent BioSolutions begins phase I trial of anthrax vaccine NuThrax
Read More
Intellect Neurosciences reports phase Ib data on Alzeimer's disease candidate OX1
Read More